Fund shareholders of Arbutus Biopharma Corp
ISIN CA03879J1003 · United States · LEI 25490064CESONAUIAS23
- Fund shareholders
- 126
- Of which ETFs
- 34 92 other funds
- Value held
- 146.1M $
- Share of capital
- 16.4 % of 197.8M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 3,659 | 16.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 3,492 | 15.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 3,483 | 15.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 3,443 | 16K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 2,580 | 10.8K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 2,291 | 10.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 1,806 | 7.6K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,708 | 7.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| 1290 VT Small Cap Value Portfolio EQ Advisors Trust | 1,625 | 7.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,513 | 6.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,025 | 4.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 961 | 4.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 810 | 3.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 772 | 3.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 506 | 2.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 494 | 2.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 417 | 1.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 383 | 1.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 341 | 1.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 276 | 1.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 212 | 954 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 155 | 722.3 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 149 | 670.5 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 48 | 223.7 $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 39 | 175.5 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Gotham Absolute Return Fund FundVantage Trust | 26 | 117 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Global Endurance Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 4.30 % | as of Mar 31, 2026 ↗ |
| Inception Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 3.85 % | as of Mar 31, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 1.55 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Insight Fund Morgan Stanley Insight Fund | 1.54 % | as of Mar 31, 2026 ↗ |
| Global Insight Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 1.44 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.66 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.50 % | as of Feb 28, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 0.19 % | as of Apr 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.14 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.14 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 126 | +4 | 32,526,535 | +0.4 % |
| 2026Q1 | 122 | -3 | 32,398,405 | +6.2 % |
| 2025Q4 | 125 | +4 | 30,496,903 | -5.5 % |
| 2025Q3 | 121 | 0 | 32,266,175 | +0.8 % |
| 2025Q2 | 121 | +3 | 32,002,854 | -2.7 % |
| 2025Q1 | 118 | +8 | 32,901,633 | +9.9 % |
| 2024Q4 | 110 | +5 | 29,950,136 | +15.1 % |
| 2024Q3 | 105 | +2 | 26,019,021 | +27.6 % |
| 2024Q2 | 103 | -1 | 20,396,622 | +6.2 % |
| 2024Q1 | 104 | -6 | 19,212,251 | +6.8 % |
| 2023Q4 | 110 | 17,981,803 |
Cite this page
Titelia. "Fund shareholders of Arbutus Biopharma Corp". https://titelia.com/en/stocks/arbutus-biopharma-corp-CA03879J1003